A clinical trial to study the Effectiveness of Topical Tranexamic Acid in controlling Anterior Nasal Bleeding.
Not Applicable
- Conditions
- Health Condition 1: R040- Epistaxis
- Registration Number
- CTRI/2022/04/041922
- Lead Sponsor
- DrSoujanya Balaraj
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult males or females presenting to ENT and Emergency Department with active anterior nasal bleeding not resolved with simple first aid measures
Exclusion Criteria
Patients with Visible bleeding vessel ,Lack of consent, Posterior nasal bleeding, Shock defined as systolic blood pressure of 90 mmHg or diastolic blood pressure of 60 mmHg, tachycardia defined as greater than 100beats per min, Major Traumatic nasal bleeding ,on Anticoagulation therapy, known Bleeding disorder, Pregnant women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiveness of Topical Tranexamic Acid to control Anterior EpistaxisTimepoint: Within 10 minutes calculated in percentage
- Secondary Outcome Measures
Name Time Method Proportion of patients who required rescue treatment that is anterior nasal packing. <br/ ><br>Proportion of patients who had re-bleeding <br/ ><br> <br/ ><br>Length of hospital stay <br/ ><br> <br/ ><br>Patient satisfaction <br/ ><br>Timepoint: After using tranexamic acid topically for 10 mins calculated in percentage. <br/ ><br>Within first 24 hours and 7 days after intervention. <br/ ><br>Calculated in hours from time of entry to exit from hospital. <br/ ><br>0-5 numeric rating scale.